Scaffold technology sales will expand through 2035, with stem cell therapy leading applications at 66.2% share. Hydrogels dominate product types with 39.6% share in 2025 and orthopedics, musculoskeletal and spine represent 51.4% of disease type demand. Market value is USD 1.7 billion in 2025 and USD 4.8 billion by 2035.